NovoCure Ltd — Director's Dealing 2019

Oct 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-10-24

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-24	Ordinary Shares	M	4580	$7.48	Acquired	67721	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-24	Options to Buy Ordinary Shares	$7.48	M	4580	Disposed	2024-02-25	Ordinary Shares (4580.0)	Direct

Footnotes

F1: Options exercised were fully vested as of the date hereof.